Daewoong Pharmaceutical Co., Ltd. (069620)
Market Closed
12 Jun, 06:30
KRX SM KRX SM Primary ₩
120,100. 00
-200
-0.1663%
₩
2.06T Market Cap
- P/E Ratio
2,400% Div Yield
29,564 Volume
- Eps
₩ 120,300
Previous Close Want to track 069620 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
069620 closed today lower at ₩120,100, a decrease of -0.1663% from yesterday's close, completing a monthly decrease of -7.1152% or -₩9,200. Over the past 12 months, 069620 stock lost -30.1744%.
069620 pays dividends to its shareholders, with the most recent payment made on Apr 13, 2026. The next estimated payment will be in In 10 months on Apr 13, 2027 for a total of ₩600.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Daewoong Pharmaceutical Co., Ltd. has completed 6 stock splits, with the recent split occurring on Dec 27, 2012.
The company's stock is traded on one exchange.
Daewoong Pharmaceutical Co., Ltd. (069620) FAQ
What is the stock price today?
The current price is ₩120,100.00.
On which exchange is it traded?
Daewoong Pharmaceutical Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 069620.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2,400%.
What is its market cap?
As of today, the market cap is 2.06T.
Has Daewoong Pharmaceutical Co., Ltd. ever had a stock split?
Daewoong Pharmaceutical Co., Ltd. had 6 splits and the recent split was on Dec 27, 2012.
Daewoong Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chang-Jae Lee CEO | KRX SM Exchange | KR7069620003 ISIN |
| KR Country | 1,644 Employees | 29 Dec 2025 Last Dividend | 27 Dec 2012 Last Split | - IPO Date |
Overview
Daewoong Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Seoul, South Korea. Since its establishment in 1945, the company has expanded its presence not only domestically but also on the international stage. Daewoong Pharmaceutical is dedicated to the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. It aims to address a multitude of therapeutic needs, making significant contributions to the healthcare sector across the globe.
Products and Services
Daewoong Pharmaceutical offers an extensive portfolio of products covering various therapeutic areas and medical devices, including:
- Central Nervous System: Products that address conditions affecting the brain and nervous system, offering relief and treatment for neurological disorders.
- Endocrinology: Treatments focused on endocrine disorders, which affect hormonal balance and can impact numerous body functions.
- Musculoskeletal: Medications designed to treat disorders of the musculoskeletal system, including muscles, bones, and joints.
- Nephrology: Products that cater to the needs of patients with kidney diseases, helping in the management and treatment of nephrological conditions.
- Antineoplastic: A range of products for the treatment of cancer, assisting in the fight against various forms of malignancies.
- Cardiovascular: Medications targeting heart and vascular diseases, aimed at improving cardiovascular health and preventing cardiac events.
- Gastrointestinal: Treatments for disorders of the gastrointestinal tract, providing relief from symptoms and improving digestive health.
- Metabolic: Products aimed at addressing metabolic disorders, including diabetes, to help maintain metabolic balance.
- Antiviral: Medications to combat viral infections, including antiviral treatments for conditions such as the flu or hepatitis.
- Analgesic: Pain relief medications that help alleviate discomfort from various conditions and improve quality of life.
- Antacid: Treatments for acid-related disorders of the stomach and esophagus, such as acid reflux and heartburn.
- Digestive Diseases: Products designed to aid in the treatment of diseases affecting the digestive system.
- Wound, Iron Supplements, and Multi-vitamins: A selection of products to aid in wound healing, supplement iron deficiencies, and provide essential vitamins and minerals for overall health.
- COVID-19 PCR Kit: Medical devices designed for the detection of COVID-19, supporting global efforts in managing the pandemic.
- COVID-19 IgG/IgM RDT: Rapid diagnostic tests for the detection of COVID-19 antibodies, facilitating quick screening and diagnosis.
- Viral Transport Medium: Medical devices used for the collection and transport of viral specimens, ensuring sample integrity for accurate testing.
Contact Information
Address: 12, Bongeunsa-ro 114-gil, Seoul, South Korea, 135-715
Phone: 82 2 550 8209
Website: https://www.daewoong.com
